Can Graves disease cause gynecomastia in males?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Graves Disease Cause Gynecomastia?

Yes, Graves disease can definitely cause gynecomastia in males, though it is an uncommon presenting symptom. 1, 2, 3, 4

Mechanism and Prevalence

Hyperthyroidism from Graves disease causes gynecomastia through hormonal imbalances—specifically through increased sex hormone-binding globulin (SHBG) and altered estrogen-to-androgen ratios. 3, 5

  • Gynecomastia occurs in 30-40% of men with Graves hyperthyroidism, though it rarely presents as the initial or predominant symptom. 3
  • The condition results from deficient androgen action or excessive estrogen action in breast tissue, which occurs in hyperthyroid states. 5
  • Hyperthyroidism should be considered as an underlying hormonal disorder when evaluating any patient with gynecomastia. 1

Clinical Presentation Patterns

Gynecomastia from Graves disease can present either unilaterally or bilaterally:

  • Bilateral progressive gynecomastia is the typical presentation pattern. 2
  • Unilateral gynecomastia can occasionally occur as the presenting manifestation, though this is less common. 2, 4
  • The breast tissue may be tender and painful, particularly in acute presentations. 2, 3, 4

Diagnostic Approach

When a male patient presents with gynecomastia, thyroid function testing should be part of the initial hormonal workup:

  • Measure serum TSH and free T4 to screen for thyrotoxicosis. 2, 4
  • If hyperthyroidism is confirmed, measure anti-TSH receptor antibodies to confirm Graves disease. 2
  • The American Urological Association recommends referring men with elevated baseline estradiol measurements to an endocrinologist to determine the underlying hormonal cause. 6
  • Assess for other signs of thyrotoxicosis including weight loss, palpitations, heat intolerance, tremors, and thyroid enlargement with bruit. 2, 4

Treatment and Resolution

Complete resolution of gynecomastia can be achieved within a few months after thyrotoxicosis is resolved in patients with recent-onset gynecomastia:

  • Treatment with anti-thyroid medication normalizes thyroid hormone, sex hormones, and SHBG levels, leading to resolution of gynecomastia. 3
  • Radioiodine ablation (RAI) is recommended for definitive treatment in young adults with very high anti-TSH receptor antibody levels and severe thyrotoxicosis. 2
  • Complete resolution without recurrence typically occurs within 3 months of achieving euthyroid status. 2
  • For men with hypogonadism contributing to gynecomastia, androgen administration might be helpful after thyroid function is normalized. 5

Important Clinical Pitfalls

  • Patients with unexplained gynecomastia or breast masses should always be screened for thyrotoxicosis, as hyperthyroid states may present deceptively with single organ system involvement. 4
  • Gynecomastia as the sole presenting symptom of Graves disease is uncommon and can distract from the correct diagnosis. 3, 4
  • Failing to assess for underlying medical conditions such as thyroid disease is a common pitfall in gynecomastia evaluation. 1
  • Most men with breast symptoms can be diagnosed clinically without imaging, but if differentiation from breast cancer cannot be made clinically, proceed with appropriate imaging based on age. 6, 7

References

Guideline

Gynecomastia Risk Factors and Assessment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Unilateral gynecomastia as an initial presentation of hyperthyroid Graves' disease.

Endocrinology, diabetes & metabolism case reports, 2021

Research

Graves' Disease Presenting as a Unilateral Breast Mass.

Case reports in medicine, 2022

Research

Gynaecomastia--pathophysiology, diagnosis and treatment.

Nature reviews. Endocrinology, 2014

Guideline

Gynecomastia Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Diagnostic Approach to Gynecomastia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the most appropriate management for a male patient with bilateral breast enlargement since age 18, presenting with grade 4 gynecomastia and significant discomfort?
What is the appropriate referral for a 27-year-old male with chronic right breast inflammation and enlargement since adolescence?
What is the treatment for androgen resistance and gynecomastia?
What is the appropriate evaluation and management for a patient experiencing breast enlargement?
What is the most appropriate management for a 25-year-old male with level 4 gynecomastia (enlargement of breast tissue in males) that has been present since age 18 and causes significant discomfort?
What is the appropriate interpretation and treatment plan for an elderly patient with TSH 762 mIU/L, normal free T4, low‑normal free T3, mildly elevated anti‑thyroglobulin antibodies, and normal anti‑TPO antibodies?
After three months of twice‑weekly physical therapy focusing on fine finger training, I have full finger flexor strength but still lack active wrist extension (wrist drop). What is the appropriate next step in management?
What is the recommended dosing regimen of caspofungin for invasive Candida infections, including loading dose, maintenance dose, hepatic impairment adjustments, pediatric dosing, and treatment duration?
What is the most likely diagnosis and immediate management for a 45‑year‑old male chronic alcoholic with fatigue, decreased appetite, oral ulcerations, peripheral edema, macrocytic anemia (hemoglobin 6.5 g/dL, MCV >100 fL), thrombocytopenia (platelet count 95 000/µL), normal white‑cell count, mildly elevated transaminases (≈2 × upper limit of normal), total bilirubin 2 mg/dL (direct 1.2 mg/dL), normal renal function, and mild splenomegaly on ultrasound?
I have only a two‑hour clinic session and several wrist‑ and finger‑extensor devices; how should I structure therapy to restore active wrist extension?
What is the Myeloproliferative Neoplasm Symptom Assessment Form (MPN‑SAF) total symptom score, its scoring range, and the thresholds that define significant symptom burden and clinically meaningful improvement?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.